The team is developing techniques and trials aimed at improving outcomes for cancer patients and reducing treatment-related toxicities, in both radical and palliative radiotherapy.
Professor Nicholas van As is clinical lead for stereotactic body radiotherapy (SBRT) at The Royal Marsden, Co-Chair of the UK SBRT consortium and the national clinical lead for NHS England’s Commissioning Through Evaluation programme for SBRT. He is running a number of clinical trials evaluating SBRT.